Edaravone
Who holds supplier records for Edaravone? 13 organisations hold a current record for Edaravone: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (7), Peru (1), Malta (1), Spain (1) and 1 other country (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Edaravone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/edaravone
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
7 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Edaravone expires 12 Nov 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Edaravone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 34751 · latest filing Jun 2020
- Cipla LimitedIndia Company GMP cert on recordActive DMF 36244 · latest filing Sept 2021
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 34449 · latest filing Dec 2019
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 35028 · latest filing Aug 2020
- INTERQUIM SAPeru Company GMP cert on recordActive DMF 40910 · latest filing Feb 2025
- MEDICHEM MANUFACTURING (MALTA) LTDMalta Company GMP cert on recordActive DMF 35211 · latest filing Oct 2020
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 34662 · latest filing Mar 2020
- Neuland Laboratories LimitedIndiaActive DMF 35204 · latest filing Sept 2020
- QUIMICA SINTETICA SASpain Company GMP cert on recordActive DMF 34776 · latest filing May 2020
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 34560 · latest filing Feb 2020
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChinaActive DMF 40202 · latest filing Jul 2024
- YUNG ZIP CHEMICAL IND CO LTDActive DMF 37241 · latest filing Jun 2022
- ZHEJIANG KINGLAND PHARMACEUTICAL CO LTDActive DMF 43324 · latest filing Dec 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (5 listed products contain Edaravone). The latest listed patent expires 12 Nov 2041. The latest listed exclusivity runs to 12 May 2029. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Edaravone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL290916).
Chemical identity
- IUPAC name
- 5-methyl-2-phenyl-4H-pyrazol-3-one
- Canonical SMILES
- CC1=NN(C(=O)C1)C2=CC=CC=C2
- InChIKey
- QELUYTUMUWHWMC-UHFFFAOYSA-N
- Synonyms
- Antipyrine related compound a, C.i. developer 1, Colorex pmp, Developer z, Edaravona, Edaravone, Jarocol pmp, MCI-186, Norphenazone, NSC-12, NSC-26139, NSC-2629
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Edaravone?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Edaravone: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India), GLAND PHARMA LTD (India), INTERQUIM SA (Peru), MEDICHEM MANUFACTURING (MALTA) LTD (Malta), MSN Laboratories Private Limited (India) and Neuland Laboratories Limited (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Edaravone Drug Master Files are active?
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 34751), Cipla Limited (DMF 36244), Dr. Reddy's Laboratories Ltd. (DMF 34449), GLAND PHARMA LTD (DMF 35028), INTERQUIM SA (DMF 40910), MEDICHEM MANUFACTURING (MALTA) LTD (DMF 35211), MSN Laboratories Private Limited (DMF 34662) and Neuland Laboratories Limited (DMF 35204) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does the FDA Orange Book list patents for products containing Edaravone?
Yes. The latest patent listed for an approved US product containing Edaravone expires 12 Nov 2041, across 5 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Edaravone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Edaravone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.